Published peptide research references
Carfilzomib
Governed registry record
3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
DOI: 10.1016/s1470-2045(15)00464-7
Source identity and connection checked by Codex (AI).
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Source identity and connection checked by Codex (AI).
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.
DOI: 10.1016/s0140-6736(21)00592-4
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Moreau P
- Dimopoulos MA
- Mikhael J
- Yong K
- Capra M
- Facon T
- Hajek R
- Špička I
- Baker R
- Kim K
- Martinez G
- Min CK
- Pour L
- Leleu X
- Oriol A
- Koh Y
- Suzuki K
- Risse ML
- Asset G
- Macé S
- Martin T
- IKEMA study group
- Palumbo A
- Joshua D
- Hájek R
- Ludwig H
- Goldschmidt H
- Rosiñol L
- Straub J
- Suvorov A
- Araujo C
- Rimashevskaya E
- Pika T
- Gaidano G
- Weisel K
- Goranova-Marinova V
- Schwarer A
- Minuk L
- Masszi T
- Karamanesht I
- Offidani M
- Hungria V
- Spencer A
- Orlowski RZ
- Gillenwater HH
- Mohamed N
- Feng S
- Chng WJ
- ENDEAVOR Investigators
- Stewart AK
- Rajkumar SV
- Siegel DS
- Mihaylov GG
- Rajnics P
- Niesvizky R
- Jakubowiak AJ
- San-Miguel JF
- Wang M
- Maisnar V
- Minarik J
- Bensinger WI
- Mateos MV
- Ben-Yehuda D
- Kukreti V
- Zojwalla N
- Tonda ME
- Yang X
- Xing B
- ASPIRE Investigators
- Zhou C
- Li C
- Luo L
- Li X
- Jia K
- He N
- Mao S
- Wang W
- Shao C
- Liu X
- Huang K
- Yu Y
- Cai X
- Chen Y
- Dai Z
- Li W
- Yu J
- Li J
- Shen F
- Wang Z
- He F
- Sun X
- Mao R
- Shi W
- Zhang J
- Jiang T
- Zhang Z
- Li F
- Ren S